FHA
SGMO

Flagship Harbor Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Flagship Harbor Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-700
Closed -$6K – 1552
2020
Q3 		$6K Hold
700
– – ﹤0.01% 1498
2020
Q2 		$6K Hold
700
– – ﹤0.01% 1530
2020
Q1 		$4K Hold
700
– – ﹤0.01% 1488
2019
Q4 		$6K Hold
700
– – ﹤0.01% 1495
2019
Q3 		$6K Hold
700
– – ﹤0.01% 1446
2019
Q2 		$7K Buy
+700
New +$7.45K ﹤0.01% 1413

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Flagship Harbor Advisors's SGMO Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2020, closing a stake of 700 shares — an estimated $6K sold.

Flagship Harbor Advisors first reported a position in SGMO in Q2 2019 and held it in 6 quarters. The position peaked at $7K in Q2 2019. 223 funds tracked by Wall St. Rank hold SGMO as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 700 SANGAMO THERAPEUTICS INC shares in Q4 2020, an estimated $6K.
  • Flagship Harbor Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2019 and held it in 6 quarters.
  • Flagship Harbor Advisors's SANGAMO THERAPEUTICS INC position peaked at $7K in Q2 2019.
  • 223 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.